Annual D&A
$540.00 K
+$18.00 K+3.45%
December 31, 2024
Summary
- As of March 12, 2025, VRDN annual depreciation & amortization is $540.00 thousand, with the most recent change of +$18.00 thousand (+3.45%) on December 31, 2024.
- During the last 3 years, VRDN annual D&A has risen by +$420.00 thousand (+350.00%).
- VRDN annual D&A is now at all-time high.
Performance
VRDN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$123.00 K
-$7000.00-5.38%
December 1, 2024
Summary
- As of March 12, 2025, VRDN quarterly depreciation & amortization is $123.00 thousand, with the most recent change of -$7000.00 (-5.38%) on December 1, 2024.
- Over the past year, VRDN quarterly D&A has dropped by -$27.00 thousand (-18.00%).
- VRDN quarterly D&A is now -18.00% below its all-time high of $150.00 thousand, reached on December 31, 2023.
Performance
VRDN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$540.00 K
-$27.00 K-4.76%
December 1, 2024
Summary
- As of March 12, 2025, VRDN TTM depreciation & amortization is $540.00 thousand, with the most recent change of -$27.00 thousand (-4.76%) on December 1, 2024.
- Over the past year, VRDN TTM D&A has increased by +$18.00 thousand (+3.45%).
- VRDN TTM D&A is now -5.59% below its all-time high of $572.00 thousand, reached on June 30, 2024.
Performance
VRDN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
VRDN Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.5% | -18.0% | +3.5% |
| 3 y3 years | +350.0% | -8.9% | +15.4% |
| 5 y5 years | +87.5% | -8.9% | +15.4% |
VRDN Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +350.0% | -18.0% | +284.4% | -5.6% | +350.0% |
| 5 y | 5-year | at high | +350.0% | -18.0% | +392.0% | -5.6% | +350.0% |
| alltime | all time | at high | +350.0% | -18.0% | +392.0% | -5.6% | +1340.0% |
Viridian Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $540.00 K(+3.4%) | - | - |
| Dec 2024 | - | $123.00 K(-5.4%) | $540.00 K(-4.8%) |
| Sep 2024 | - | $130.00 K(-8.5%) | $567.00 K(-0.9%) |
| Jun 2024 | - | $142.00 K(-2.1%) | $572.00 K(+1.8%) |
| Mar 2024 | - | $145.00 K(-3.3%) | $562.00 K(+7.7%) |
| Dec 2023 | $522.00 K(+104.7%) | $150.00 K(+11.1%) | $522.00 K(+11.5%) |
| Sep 2023 | - | $135.00 K(+2.3%) | $468.00 K(+18.5%) |
| Jun 2023 | - | $132.00 K(+25.7%) | $395.00 K(+23.4%) |
| Mar 2023 | - | $105.00 K(+9.4%) | $320.00 K(+25.5%) |
| Dec 2022 | $255.00 K(+112.5%) | $96.00 K(+54.8%) | $255.00 K(+33.5%) |
| Sep 2022 | - | $62.00 K(+8.8%) | $191.00 K(+20.1%) |
| Jun 2022 | - | $57.00 K(+42.5%) | $159.00 K(+25.2%) |
| Mar 2022 | - | $40.00 K(+25.0%) | $127.00 K(+5.8%) |
| Dec 2021 | $120.00 K(-49.8%) | $32.00 K(+6.7%) | $120.00 K(-13.0%) |
| Sep 2021 | - | $30.00 K(+20.0%) | $138.00 K(-16.4%) |
| Jun 2021 | - | $25.00 K(-24.2%) | $165.00 K(-19.1%) |
| Mar 2021 | - | $33.00 K(-34.0%) | $204.00 K(-14.6%) |
| Dec 2020 | $239.00 K(-17.0%) | $50.00 K(-12.3%) | $239.00 K(-8.8%) |
| Sep 2020 | - | $57.00 K(-10.9%) | $262.00 K(-5.1%) |
| Jun 2020 | - | $64.00 K(-5.9%) | $276.00 K(-2.5%) |
| Mar 2020 | - | $68.00 K(-6.8%) | $283.00 K(-1.7%) |
| Dec 2019 | $288.00 K(+2.5%) | $73.00 K(+2.8%) | $288.00 K(-0.7%) |
| Sep 2019 | - | $71.00 K(0.0%) | $290.00 K(+1.0%) |
| Jun 2019 | - | $71.00 K(-2.7%) | $287.00 K(+0.7%) |
| Mar 2019 | - | $73.00 K(-2.7%) | $285.00 K(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $281.00 K(-8.8%) | $75.00 K(+10.3%) | $281.00 K(-2.1%) |
| Sep 2018 | - | $68.00 K(-1.4%) | $287.00 K(-3.7%) |
| Jun 2018 | - | $69.00 K(0.0%) | $298.00 K(-2.0%) |
| Mar 2018 | - | $69.00 K(-14.8%) | $304.00 K(-1.3%) |
| Dec 2017 | $308.00 K(+63.0%) | $81.00 K(+2.5%) | $308.00 K(+12.4%) |
| Sep 2017 | - | $79.00 K(+5.3%) | $274.00 K(+13.2%) |
| Jun 2017 | - | $75.00 K(+2.7%) | $242.00 K(+12.6%) |
| Mar 2017 | - | $73.00 K(+55.3%) | $215.00 K(+13.8%) |
| Dec 2016 | $189.00 K(+2.7%) | $47.00 K(0.0%) | $189.00 K(0.0%) |
| Sep 2016 | - | $47.00 K(-2.1%) | $189.00 K(0.0%) |
| Jun 2016 | - | $48.00 K(+2.1%) | $189.00 K(+1.6%) |
| Mar 2016 | - | $47.00 K(0.0%) | $186.00 K(+1.1%) |
| Dec 2015 | $184.00 K(+27.8%) | $47.00 K(0.0%) | $184.00 K(+5.1%) |
| Sep 2015 | - | $47.00 K(+4.4%) | $175.00 K(+8.0%) |
| Jun 2015 | - | $45.00 K(0.0%) | $162.00 K(+5.9%) |
| Mar 2015 | - | $45.00 K(+18.4%) | $153.00 K(+6.3%) |
| Dec 2014 | $144.00 K(-2.7%) | $38.00 K(+11.8%) | $144.00 K(+1.3%) |
| Sep 2014 | - | $34.00 K(-5.6%) | $142.10 K(-2.0%) |
| Jun 2014 | - | $36.00 K(0.0%) | $145.00 K(-1.0%) |
| Mar 2014 | - | $36.00 K(-0.3%) | $146.50 K(-1.0%) |
| Dec 2013 | $148.00 K(+2.6%) | $36.10 K(-2.2%) | $148.00 K(+32.3%) |
| Sep 2013 | - | $36.90 K(-1.6%) | $111.90 K(+49.2%) |
| Jun 2013 | - | $37.50 K(0.0%) | $75.00 K(+100.0%) |
| Mar 2013 | - | $37.50 K | $37.50 K |
| Dec 2012 | $144.30 K | - | - |
FAQ
- What is Viridian Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Viridian Therapeutics?
- What is Viridian Therapeutics annual D&A year-on-year change?
- What is Viridian Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly D&A year-on-year change?
- What is Viridian Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Viridian Therapeutics?
- What is Viridian Therapeutics TTM D&A year-on-year change?
What is Viridian Therapeutics annual depreciation & amortization?
The current annual D&A of VRDN is $540.00 K
What is the all time high annual D&A for Viridian Therapeutics?
Viridian Therapeutics all-time high annual depreciation & amortization is $540.00 K
What is Viridian Therapeutics annual D&A year-on-year change?
Over the past year, VRDN annual depreciation & amortization has changed by +$18.00 K (+3.45%)
What is Viridian Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of VRDN is $123.00 K
What is the all time high quarterly D&A for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly depreciation & amortization is $150.00 K
What is Viridian Therapeutics quarterly D&A year-on-year change?
Over the past year, VRDN quarterly depreciation & amortization has changed by -$27.00 K (-18.00%)
What is Viridian Therapeutics TTM depreciation & amortization?
The current TTM D&A of VRDN is $540.00 K
What is the all time high TTM D&A for Viridian Therapeutics?
Viridian Therapeutics all-time high TTM depreciation & amortization is $572.00 K
What is Viridian Therapeutics TTM D&A year-on-year change?
Over the past year, VRDN TTM depreciation & amortization has changed by +$18.00 K (+3.45%)